One of these is low level laser therapy (LLLT) which, in a systematic review of which genetic hair loss treatments work, carried out in Canada in 2017, the three forms identified as being the most effective were high strength minoxidil (men and women), finasteride 1mg (men only) and LLLT (men and women).
The HairMax LaserBand devices – the LaserBand 41 and LaserBand 82 – are FDA-cleared low level laser therapy devices which use photobiostimulation technology to stimulate the follicles at a cellular level.
They are portable products with an ergonomic, headband-style design that is used for a few minutes, three times per week.
The underside of the Comfortflex self-adjusting band is embedded with medical-grade lasers and teeth which part the hair, allowing the lasers to get straight to the scalp for maximum delivery. The LaserBand 41 contains 41 of these lasers, whilst the LaserBand 82 contains 82.
According to research quoted by HairMax, participants using their Laser Band devices in clinical studies saw 129 new hairs per square inch grow as a result; the company claims the LaserBands have a 93% success rate.
The company advises its devices are “indicated to treat Androgenetic Alopecia, and promote hair growth in males who have Norwood Hamilton Classifications of IIa to V and in females who have Ludwig (Savin) I-4, II-1, II-2, or frontal patterns of hair loss and who both have Fitzpatrick Skin Types I to IV.”
With regards to the skin types for which the LaserBand is suitable, Fitzpatrick Skin Types I to IV are recommended solely because those are the only ones the device has been officially trialled on. HairMax has confirmed that its devices are, however, suitable for all skin colours.
Additionally, although the LaserBands have only been tested on men and women with genetic hair loss, the company has also advised it can be used on other hair loss conditions, including Traction Alopecia.
This is also something Belgravia has seen over the years, with clients of all ethnicities and various different reasons for their shedding, reporting positive results from their LaserBand use to our hair loss specialists.
HairMax has been developing LLLT devices for over twenty years, and was the first company to have a home-use medical LLLT product for hair loss and hair regrowth awarded FDA-clearance. This was the LaserBand’s predecessor, the LaserComb in 2007.
The LaserBand 41 and the more powerful LaserBand 82 are both available from Belgravia hair loss clinics and can be purchased for a special, lower price in certain cases when bought alongside an annual hair loss treatment course.
The LaserBand 82 costs £699, or £549 if purchased with selected treatment courses.
The LaserBand 41 costs £499, or £349 if purchased with selected treatment courses.
For further details, please contact the centre or speak to your dedicated Treatment Advisor.
Submit an instant online consultation so that one of Belgravia’s hair loss specialists can diagnose your condition and recommend an effective course of treatment, wherever you live.